<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="monograph" /><meta name="keywords" content="Mifepristone; Gemeprost; Mifegyne; Mifepristone" /><meta name="IX" content="Gemeprost; Mifegyne; Mifepristone" /><meta name="IXM" content="Mifepristone" /><title>MIFEPRISTONE: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="129508.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="129508.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=129508.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2074.htm">7 Obstetrics, gynaecology, and urinary-tract disorders</a> &gt; <a href="4483.htm">7.1 Drugs used in obstetrics</a> &gt; <a href="129505.htm">7.1.2 Mifepristone</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="129505.htm" title="Previous: 7.1.2 Mifepristone">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129510.htm#_129510" title="Next: Mifegyne®">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a300042.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mifepristone</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Oxytocics 76:00</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/19516-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mifepristone</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: M &gt; Interactions of Mifepristone</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="4484.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">7.1.1 Prostaglandins and oxytocics</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.1 Drugs used in obstetrics</p></div></li><li><a href="4497.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">GEMEPROST</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.1 Drugs used in obstetrics &gt; 7.1.1 Prostaglandins and oxytocics</p></div></li><li><a href="4498.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gemeprost</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 7 Obstetrics, gynaecology, and urinary-tract disorders &gt; 7.1 Drugs used in obstetrics &gt; 7.1.1 Prostaglandins and oxytocics &gt; GEMEPROST</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22mifepristone%22%22mifepristone%22%22gemeprost%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1100.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mifepristone</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; M</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/8088-w.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gemeprost</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Obstetric Drugs &gt; Drug Monographs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/19516-z.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mifepristone</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Obstetric Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index (2)</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/04387.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Gemeprost</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; G &gt; GE</p></div></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/06186.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mifepristone</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; M &gt; MI</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E2E3E0R0D2195.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Mifepristone</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; M</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_129508">MIFEPRISTONE</h1><?highlighter on?><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i614.htm" title="Go to appendix 1">Mifepristone</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under dose</p></div><div class="cAF"><h2>Cautions</h2> <p class="cAF">asthma (avoid if severe
and uncontrolled); haemorrhagic disorders and anticoagulant therapy; prosthetic heart valve or history of endocarditis (see <a title=" Antibacterial drugs" href="3705.htm#_3705">section 5.1</a> table 2); risk factors for or existing cardiovascular
disease; adrenal suppression (may require corticosteroid); <b>interactions</b>: Appendix
1 (<span>mifepristone</span>)</p><div class="cAV"><h3>Important</h3> <p class="cAX">For warnings relating to use of gemeprost
in a patient undergoing induction of abortion with mifepristone, see
under Gemeprost</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">uncontrolled severe asthma; suspected ectopic pregnancy (use other specific
means of termination); chronic adrenal failure; acute porphyria (<a title=" Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">manufacturer advises avoid</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">manufacturer advises avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">gastro-intestinal cramps; uterine contractions,
vaginal bleeding (sometimes severe) may occur between administration
of <span>mifepristone</span> and surgery (and rarely abortion
may occur before surgery); <i>less commonly</i> hypersensitivity
reactions including rash and urticaria; <i>rarely</i> hypotension,
malaise, headache, fever, hot flushes, dizziness, and chills; infections
(including toxic shock syndrome) also reported</p></div><div class="cAF"><h2>Dose</h2> <p class="cR">Medical termination of intra-uterine pregnancy of
up to 49 days gestation, <span class="cU">by mouth</span>, mifepristone 600 mg
as a single dose under medical supervision followed 36–48 hours later
(unless abortion already complete) by gemeprost 1 mg <span class="cU">by vagina</span> <i>or</i> misoprostol 400 micrograms <span class="cU">by mouth</span> [unlicensed]; alternative regimen, mifepristone 200 mg <span class="cU">by
mouth</span> as a single dose followed 36–48 hours later (unless
abortion already complete) by gemeprost 1 mg <span class="cU">by vagina</span>; observe for at least 3 hours (or until bleeding or pain at acceptable
level); follow-up visit within 2 weeks to verify complete expulsion
and to assess vaginal bleeding</p><p class="cR">Medical termination of intra-uterine pregnancy of
50–63 days gestation, <span class="cU">by mouth</span>, mifepristone 600 mg
(200 mg also effective) as a single dose under medical supervision,
followed 36–48 hours later (unless abortion already complete) by gemeprost
1 mg <span class="cU">by vagina</span>; observe for at least 3 hours (or until
bleeding or pain at acceptable level); follow-up visit within 2 weeks
to verify complete expulsion and to assess vaginal bleeding</p><p class="cR">Cervical ripening before mechanical cervical dilatation
for termination of pregnancy of up to 84 days gestation, <span class="cU">by
mouth</span>, mifepristone 200 mg as a single dose under medical
supervision 36–48 hours before procedure</p><p class="cR">Termination of pregnancy of 13–24 weeks gestation
(in combination with a prostaglandin), <span class="cU">by mouth</span>, <span>mifepristone</span> 600 mg (200 mg may be effective) as a single
dose under medical supervision followed 36–48 hours later by <span>gemeprost</span> 1 mg <span class="cU">by vagina</span> every 3 hours up
to max. 5 mg <i>or</i> misoprostol (see <a title="sub-section: Mifepristone" href="129505.htm#_129505">above</a> [unlicensed]); if abortion does not occur,
24 hours after start of treatment repeat course of <span>gemeprost</span> 1 mg <span class="cU">by vagina</span> up to max. 5 mg; follow-up visit after
appropriate interval to assess vaginal bleeding recommended</p><div class="cAT"><h3>Note</h3> <p class="cAX">Careful monitoring of blood pressure and
pulse essential for 3 hours after administration of <span>gemeprost</span> pessary (risk of profound hypotension)</p></div><p class="cR">Labour induction in fetal death <i>in utero</i> where prostaglandin or oxytocin inappropriate, <span class="cU">by mouth</span>, mifepristone 600 mg daily as a single dose for 2 days under medical
supervision; if labour not started within 72 hours of first dose,
another method should be used</p></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="129510.htm#_129510" title="Mifegyne®">Mifegyne®</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="129505.htm">Previous: 7.1.2 Mifepristone</a> | <a class="top" href="129508.htm#">Top</a> | <a accesskey="]" href="129510.htm#_129510" title="Mifegyne®">Next: Mifegyne®</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>